“…二 [(5-甲基)-2-呋喃基](2-噻吩基) 甲烷(3i) [8a] : 1 H NMR (300 MHz, CDCl 3 ) δ: 2.26 (s, 6H), 5.56 (s, 1H), 5.87 (s, 2H), 5.95 (s, 2H), 6.87~6.93 (m, 2H), 7.17 (d, 1H, J= 4.9 Hz); 13 C NMR (75 MHz, CDCl 3 ) δ: 40. 4, 106.4, 108.1, 124.7, 125.8, 126.7, 143.4, 151.6, 152.4. 3-[二(5-甲基-2-呋喃基)甲基]-1H-吲哚(3j) [8a] : 1 H NMR (300 MHz, CDCl 3 ) δ: 2.25 (s, 6H), 5.58 (s, 1H), 5.85 (s, 2H), 5.89 (s, 2H), 6.93 (s, 1H), 7.03 (uneven triplet, 1H, J=7.6, 7.3 Hz), 7.14 (uneven triplet, 1H, J=7.9, 7.1 Hz), 7.28 (d, J=8.1 Hz, 1H), 7.47 (d, J=7.9 Hz, 1H), 7.91 (s, 1H); 13 C NMR (75 MHz, CDCl 3 ) δ: 13.7, 36.8, 106.1, 107.5, 111.1, 115.1, 119.4, 119.6, 122.0, 122.9, 126.5, 136.4, 150.9, 153.0. 四[(5-甲基)-2-呋喃基]-1, 4-二次甲基苯(3k) [8a] : 1 H NMR (300 MHz, CDCl 3 ) δ: 2.24 (s, 12H), 5.30 (s, 2H), 5.86 (s, 8H), 7.17 (s, 4H); 13 C NMR (75 MHz, CDCl 3 ) δ: 13.6, 44.7, 106.0, 108.1, 128.4, 138.6, 151.3, 152.8.…”